203 related articles for article (PubMed ID: 24794793)
1. Imaging strategies before beginning treatment of colorectal liver metastases.
Legou F; Chiaradia M; Baranes L; Pigneur F; Zegai B; Djabbari M; Calderaro J; Laurent A; Kobeiter H; Rahmouni A; Luciani A
Diagn Interv Imaging; 2014 May; 95(5):505-12. PubMed ID: 24794793
[TBL] [Abstract][Full Text] [Related]
2. Imaging modalities for the staging of patients with colorectal cancer.
Bipat S; Niekel MC; Comans EF; Nio CY; Bemelman WA; Verhoef C; Stoker J
Neth J Med; 2012 Jan; 70(1):26-34. PubMed ID: 22271811
[TBL] [Abstract][Full Text] [Related]
3. Optimal imaging sequence for staging in colorectal liver metastases: analysis of three hypothetical imaging strategies.
Yip VS; Collins B; Dunne DF; Koay MY; Tang JM; Wieshmann H; Fenwick SW; Poston GJ; Malik HZ
Eur J Cancer; 2014 Mar; 50(5):937-43. PubMed ID: 24332574
[TBL] [Abstract][Full Text] [Related]
4. Response assessment of colorectal liver metastases with contrast enhanced CT/18F-FDG PET.
García Vicente AM; Domínguez Ferreras E; Sánchez Pérez V; Poblete García VM; Villa Guzmán JC; Jiménez Aragón F; Pineda Pineda MD; Molino Trinidad C; Soriano Castrejón Á
Eur J Radiol; 2013 Jun; 82(6):e255-61. PubMed ID: 23414715
[TBL] [Abstract][Full Text] [Related]
5. Imaging and treatment of patients with colorectal liver metastases in the Netherlands: a survey.
Bipat S; van Leeuwen MS; Ijzermans JN; Bossuyt PM; Greve JW; Stoker J
Neth J Med; 2006 May; 64(5):147-51. PubMed ID: 16702613
[TBL] [Abstract][Full Text] [Related]
6. Current status of imaging and emerging techniques to evaluate liver metastases from colorectal carcinoma.
Sahani DV; Bajwa MA; Andrabi Y; Bajpai S; Cusack JC
Ann Surg; 2014 May; 259(5):861-72. PubMed ID: 24509207
[TBL] [Abstract][Full Text] [Related]
7. Liver metastases from colorectal cancer: imaging with superparamagnetic iron oxide (SPIO)-enhanced MR imaging, computed tomography and positron emission tomography.
Rappeport ED; Loft A
Abdom Imaging; 2007; 32(5):624-34. PubMed ID: 17710359
[TBL] [Abstract][Full Text] [Related]
8. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
[TBL] [Abstract][Full Text] [Related]
9. The added value of PET/Ce-CT/DW-MRI fusion in assessment of hepatic focal lesions: PET/Ce-CT/DW-MRI fusion in hepatic focal lesion.
Salem S; Houseni M; Zidan L; Kandil A
Nucl Med Biol; 2015 Jul; 42(7):637-42. PubMed ID: 25907467
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography/computed tomographic scans compared to computed tomographic scans for detecting colorectal liver metastases: a systematic review.
Patel S; McCall M; Ohinmaa A; Bigam D; Dryden DM
Ann Surg; 2011 Apr; 253(4):666-71. PubMed ID: 21475005
[TBL] [Abstract][Full Text] [Related]
11. Imaging diagnosis of colorectal liver metastases.
Xu LH; Cai SJ; Cai GX; Peng WJ
World J Gastroenterol; 2011 Nov; 17(42):4654-9. PubMed ID: 22180707
[TBL] [Abstract][Full Text] [Related]
12. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.
Cantwell CP; Setty BN; Holalkere N; Sahani DV; Fischman AJ; Blake MA
J Comput Assist Tomogr; 2008; 32(5):738-44. PubMed ID: 18830103
[TBL] [Abstract][Full Text] [Related]
13. Invited editorial: Response to therapy assessment of colorectal liver metastasis.
Maffione AM; Rampin L; Blickman JG; Rubello D
Eur J Radiol; 2013 Jun; 82(6):903-4. PubMed ID: 23518147
[No Abstract] [Full Text] [Related]
14. Impact of 18F-FDG PET/CT on therapeutic decisions in patients with colorectal cancer and liver metastases.
Georgakopoulos A; Pianou N; Kelekis N; Chatziioannou S
Clin Imaging; 2013; 37(3):536-41. PubMed ID: 23116727
[TBL] [Abstract][Full Text] [Related]
15. Critical questions in the imaging of colorectal hepatic metastases.
Koh DM; Berry J
Cancer Imaging; 2008 Oct; 8 Spec No A(Spec Iss A):S69-78. PubMed ID: 18852083
[TBL] [Abstract][Full Text] [Related]
16. Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.
Abbadi RA; Sadat U; Jah A; Praseedom RK; Jamieson NV; Cheow HK; Whitley S; Ford HE; Wilson CB; Harper SJ; Huguet EL
J Surg Oncol; 2014 Sep; 110(3):313-9. PubMed ID: 24737685
[TBL] [Abstract][Full Text] [Related]
17. Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques.
Kim HJ; Lee SS; Byun JH; Kim JC; Yu CS; Park SH; Kim AY; Ha HK
Radiology; 2015 Mar; 274(3):712-22. PubMed ID: 25286324
[TBL] [Abstract][Full Text] [Related]
18. An overview of imaging techniques for liver metastases management.
Matos AP; Altun E; Ramalho M; Velloni F; AlObaidy M; Semelka RC
Expert Rev Gastroenterol Hepatol; 2015; 9(12):1561-76. PubMed ID: 26414180
[TBL] [Abstract][Full Text] [Related]
19. Liver metastases of colorectal cancer: US, CT or MR?
Schima W; Kulinna C; Langenberger H; Ba-Ssalamah A
Cancer Imaging; 2005 Nov; 5 Spec No A(Spec No A):S149-56. PubMed ID: 16361131
[TBL] [Abstract][Full Text] [Related]
20. Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab.
Lastoria S; Piccirillo MC; Caracò C; Nasti G; Aloj L; Arrichiello C; de Lutio di Castelguidone E; Tatangelo F; Ottaiano A; Iaffaioli RV; Izzo F; Romano G; Giordano P; Signoriello S; Gallo C; Perrone F
J Nucl Med; 2013 Dec; 54(12):2062-9. PubMed ID: 24136935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
